Evaluation of the effect of shockwave therapy on pain of patient with post stroke hemiplegic shoulder pain

The effect of shockwave therapy on pain of patient with post stroke hemiplegic shoulder pain

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20171030037093N9

Enrollment

Registered

2019-05-06

Start date

2019-06-01

Completion date

Unknown

Last updated

2019-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder pain. Pain in shoulder

Interventions

Intervention 1: Intervention group: Under treatment with shockwave, the number of sessions is 5 sessions, which consists of 3 sessions of focus with intervals and 5 radial sessions with intervals of t

Eligibility

Sex/Gender

All

Age

20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Satisfaction to participate in the study Age group 20-80 years At least 3 months have passed since the stroke occurred. Shoulder pain and shoulder paralysis have started after ischemic stroke. The severity of the shoulder pain is based on the vas criterion of at least 4 or more for at least 3 months.

Exclusion criteria

Exclusion criteria: Not being able to express the severity of pain Surgical history on the shoulder Use of oral hives 3 days before the study Intraocular infusion or other interventions affecting shoulder in the past month Taking high dose warfarin (INR above 4) Trauma history on shoulders Patients receiving a cardiac pacemaker Moderate to severe depression crps based on patient examination History of shoulder pain before a stroke Based on the examinations, no mechanical causes for pain should be noted.

Design outcomes

Primary

Measure	Time frame
Severe shoulder pain. Timepoint: The beginning of the study, the end of treatment, and weeks 4 and 8 after treatment. Method of measurement: Vas questionnaire.;Shoulder performance. Timepoint: The beginning of the study, the end of treatment, and weeks 4 and 8 after treatment. Method of measurement: Examination and questionnaire.;The range of shoulder motion. Timepoint: The beginning of the study, the end of treatment, and weeks 4 and 8 after treatment. Method of measurement: Goniometer.;Time to start shoulder pain. Timepoint: The beginning of the study, the end of treatment, and weeks 4 and 8 after treatment. Method of measurement: Information Form.	—

Measure

Time frame

Severe shoulder pain. Timepoint: The beginning of the study, the end of treatment, and weeks 4 and 8 after treatment. Method of measurement: Vas questionnaire.;Shoulder performance. Timepoint: The beginning of the study, the end of treatment, and weeks 4 and 8 after treatment. Method of measurement: Examination and questionnaire.;The range of shoulder motion. Timepoint: The beginning of the study, the end of treatment, and weeks 4 and 8 after treatment. Method of measurement: Goniometer.;Time to start shoulder pain. Timepoint: The beginning of the study, the end of treatment, and weeks 4 and 8 after treatment. Method of measurement: Information Form.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShila Haghighat

Esfahan University of Medical Sciences

Haghighatshila@gmail.com+98 31 3670 0666

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026